Personalis Share Price Today
(NASDAQ: PSNL)

Name: Personalis Share Price Today (NASDAQ: PSNL) - Personalis Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Personalis share price is $4.49 & ₹390.49 as on 6 Mar 2025, 2.30 'hrs' IST

$4.49

▲

0.38

(9.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Personalis share price in Dollar and Rupees. Guide to invest in Personalis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Personalis, along with analyst recommendations, forecasts, and comprehensive financials.

Personalis share price movements

Today's Low: $4.04
Today's High: $4.50
$4.49
10.03%
Downside
Day's Volatility :10.13%
Upside
0.11%
52 Weeks Low: $1.14
52 Weeks High: $7.20
$4.49
74.72%
Downside
52 Weeks Volatility :84.24%
Upside
37.64%

Personalis (PSNL) Returns

Period	Personalis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	8.73%	2.1%	0.0%
6 Months	-20.35%	-4.1%	0.0%
1 Year	134.86%	2.2%	0.0%
3 Years	-55.62%	11.8%	-11.6%

Personalis (PSNL) Key Statistics

in dollars & INR

Previous Close	$4.11
Open	$4.14
Today's High	$4.495
Today's Low	$4.039814
Market Capitalization	$348.5M
Today's Volume	$251.1K
52 Week High	$7.2
52 Week Low	$1.135
Revenue TTM	$84.6M
EBITDA	$-57.3M
Earnings Per Share (EPS)	$-1.37
Profit Margin	-96.06%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.91%

How to invest in Personalis Stock (PSNL) from India?

It is very easy for Indian residents to invest directly in Personalis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Personalis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Personalis or PSNL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Personalis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Personalis shares which would translate to 0.194 fractional shares of Personalis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Personalis, in just a few clicks!

Returns in Personalis (PSNL) for Indian investors in Rupees

The Personalis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Personalis investment value today

Current value as on today

₹2,61,534

Returns

₹1,61,534

(+161.53%)

Returns from Personalis Stock

₹1,56,571 (+156.57%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Personalis (PSNL)

-45%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Personalis Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Personalis

ARK Investment Management LLC
8.00%
AIGH Capital Management, LLC
4.49%
BlackRock Inc
3.49%
Vanguard Group Inc
2.05%
Millennium Management LLC
1.56%
Blue Water Life Science Advisors, LLC
1.34%

Analyst Recommendation on Personalis

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Personalis(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Personalis Stock (PSNL)

What analysts predicted

Upside of 60.36%

Target:

$7.20

Current:

$4.49

Insights on Personalis Stock (Ticker Symbol: PSNL)

Price Movement
In the last 1 year, PSNL stock has moved up by 141.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 25.70M → 16.8M (in $), with an average decrease of 34.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -39.08M → -16.42M (in $), with an average increase of 138.0% per quarter
PSNL vs TMO (3 yr)
In the last 3 years, Personalis Inc has experienced a drawdown of -53.9%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 48.3%

PSNL Personalis Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$65.2M	↑ 72.62%
Net Income	$-25.1M	↑ 26.14%
Net Profit Margin	-38.47%	↑ 14.17%

	FY20	Y/Y Change
Revenue	$78.6M	↑ 20.61%
Net Income	$-41.3M	↑ 64.57%
Net Profit Margin	-52.49%	↓ 14.02%

	FY21	Y/Y Change
Revenue	$85.5M	↑ 8.7%
Net Income	$-65.2M	↑ 58.01%
Net Profit Margin	-76.29%	↓ 23.8%

	FY22	Y/Y Change
Revenue	$65.0M	↓ 23.92%
Net Income	$-113.3M	↑ 73.73%
Net Profit Margin	-174.2%	↓ 97.91%

	FY23	Y/Y Change
Revenue	$73.5M	↑ 12.97%
Net Income	$-108.3M	↓ 4.43%
Net Profit Margin	-147.38%	↑ 26.82%

	FY24	Y/Y Change
Revenue	$84.6M	↑ 15.15%
Net Income	$-81.3M	↓ 24.94%
Net Profit Margin	-96.06%	↑ 51.32%

	Q3 FY23	Q/Q Change
Revenue	$18.2M	↑ 9.27%
Net Income	$-29.1M	↑ 21.47%
Net Profit Margin	-159.47%	↓ 16.02%

	Q4 FY23	Q/Q Change
Revenue	$19.7M	↑ 7.83%
Net Income	$-26.6M	↓ 8.64%
Net Profit Margin	-135.12%	↑ 24.35%

	Q1 FY24	Q/Q Change
Revenue	$19.5M	↓ 0.76%
Net Income	$-13.0M	↓ 51.22%
Net Profit Margin	-66.42%	↑ 68.7%

	Q2 FY24	Q/Q Change
Revenue	$22.6M	↑ 15.65%
Net Income	$-12.8M	↓ 1.28%
Net Profit Margin	-56.7%	↑ 9.72%

	Q3 FY24	Q/Q Change
Revenue	$25.7M	↑ 13.86%
Net Income	$-39.1M	↑ 205.34%
Net Profit Margin	-152.04%	↓ 95.34%

	Q4 FY24	Q/Q Change
Revenue	$16.8M	↓ 34.65%
Net Income	$-16.4M	↓ 57.98%
Net Profit Margin	-97.77%	↑ 54.27%

	FY19	Y/Y Change
Profit	$22.1M	↑ 87.04%

	FY20	Y/Y Change
Profit	$20.1M	↓ 8.9%

	FY21	Y/Y Change
Profit	$31.7M	↑ 57.39%

	FY22	Y/Y Change
Profit	$13.4M	↓ 57.83%

	FY23	Y/Y Change
Profit	$18.2M	↑ 36.39%

	FY24	Y/Y Change
Profit	$-57.8M	↓ 417.38%

	Q3 FY23	Q/Q Change
Profit	$3.5M	↓ 27.36%

	Q4 FY23	Q/Q Change
Profit	$5.2M	↑ 49.53%

	Q1 FY24	Q/Q Change
Profit	$5.5M	↑ 5.53%

	Q2 FY24	Q/Q Change
Profit	$8.0M	↑ 46.31%

	Q3 FY24	Q/Q Change
Profit	$8.7M	↑ 8.81%

	Q4 FY24	Q/Q Change
Profit	$-12.3M	↓ 240.08%

	FY19	Y/Y Change
Operating Cash Flow	$-18.1M	↓ 424.28%
Investing Cash Flow	$-81.6M	↑ 938.96%
Financing Cash Flow	$134.9M	↓ 22933.84%

	FY20	Y/Y Change
Operating Cash Flow	$-42.7M	↑ 136.06%
Investing Cash Flow	$-65.1M	↓ 20.15%
Financing Cash Flow	$121.3M	↓ 10.14%

	FY21	Y/Y Change
Operating Cash Flow	$-70.8M	↑ 66.06%
Investing Cash Flow	$-60.1M	↓ 7.79%
Financing Cash Flow	$169.7M	↑ 39.94%

	FY22	Y/Y Change
Operating Cash Flow	$-70.2M	↓ 0.84%
Investing Cash Flow	$52.5M	↓ 187.46%
Financing Cash Flow	$1.4M	↓ 99.2%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-16.7M	↑ 60.18%
Investing Cash Flow	$-8.6M	↓ 144.02%
Financing Cash Flow	$290.0K	↓ 68.65%

Personalis Technicals Summary

Sell

Neutral

Buy

Personalis is currently in a neutral trading position according to technical analysis indicators.

Personalis (PSNL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Personalis Inc	-15.95%	-20.35%	134.86%	-55.62%	-43.31%
Agilent Technologies Inc.	-16.31%	-11.06%	-15.84%	-5.59%	73.94%
Idexx Laboratories, Inc.	-5.04%	-5.88%	-20.78%	-14.63%	81.86%
Thermo Fisher Scientific, Inc.	-11.02%	-14.88%	-12.67%	-3.4%	74.9%
Danaher Corp.	-4.23%	-22.21%	-18.58%	-21.71%	45.43%
Iqvia Holdings Inc.	-8.23%	-26.02%	-27.43%	-15.27%	48.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Personalis Inc	NA	NA	NA	-1.04	-0.49	-0.17	NA	2.38
Agilent Technologies Inc.	28.22	28.22	2.06	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.97	40.97	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.62	31.62	2.05	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.81	38.81	2.07	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.51	24.51	0.99	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Personalis Inc	Buy	$348.5M	-43.31%	NA	-96.06%
Agilent Technologies Inc.	Buy	$35.1B	73.94%	28.22	19.27%
Idexx Laboratories, Inc.	Buy	$35.6B	81.86%	40.97	22.78%
Thermo Fisher Scientific, Inc.	Buy	$197.5B	74.9%	31.62	14.77%
Danaher Corp.	Buy	$147.0B	45.43%	38.81	16.33%
Iqvia Holdings Inc.	Buy	$32.4B	48.04%	24.51	8.91%

About Personalis

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Organization	Personalis
Employees	0
CEO	Mr. Christopher M. Hall
Industry	Biotechnology

Management People of Personalis

Name	Title
Mr. Christopher M. Hall	President, CEO & Director
Mr. Aaron L. Tachibana	CFO & COO
Dr. Russ B. Altman M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Michael P. Snyder Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board
Mr. Michael J Fitzpatrick	Vice President of Worldwide Sales
Dr. Christian Haudenschild Ph.D.	Senior Vice President of Genomic Laboratory Operations
Mr. Stephane Mouradian Ph.D.	Senior Vice President of Business Development
Ms. Deepshikha Bhandari	Senior Vice President of Regulatory, Quality & Clinical Compliance

Important FAQs about investing in PSNL Stock from India :

What is Personalis share price today?

Personalis share price today stands at $4.49, Open: $4.14 ; Previous Close: $4.11 ; High: $4.50 ; Low: $4.04 ; 52 Week High: $7.20 ; 52 Week Low: $1.14.

The stock opens at $4.14, after a previous close of $4.11. The stock reached a daily high of $4.50 and a low of $4.04, with a 52-week high of $7.20 and a 52-week low of $1.14.

Can Indians buy Personalis shares?

Yes, Indians can invest in the Personalis (PSNL) from India.

With INDmoney, you can buy Personalis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Personalis at zero transaction cost.

How can I buy Personalis shares from India?

It is very easy to buy Personalis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Personalis (PSNL) be purchased?

Yes, you can buy fractional shares of Personalis with INDmoney app.

What are the documents required to start investing in Personalis stocks?

To start investing in Personalis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.